An updated database of human maximum skin fluxes and epidermal permeability coefficients for drugs, xenobiotics, and other solutes applied as aqueous solutions.
An updated database of human maximum skin fluxes and epidermal permeability coefficients for drugs, xenobiotics, and other solutes applied as aqueous solutions.
复制标题
DOI:
10.1016/j.dib.2022.108242
复制
发表时间:
2022-06
期刊:
影响因子:
1.2
通讯作者:
Roberts, Michael S.
中科院分区:
文献类型:
--
作者:
Cheruvu, Hanumanth Srikanth;Liu, Xin;Grice, Jeffrey E.;Roberts, Michael S.
关键词:
The dataset represented in this article is referred to by the review article entitled “Topical drug delivery: history, percutaneous absorption, and product development” (MS Roberts et al., 2021). The dataset contains maximal flux (Jmax), and permeability coefficient (kp) values collated from In Vitro human skin Permeation Test (IVPT) reports published to date for various drugs, xenobiotics, and other solutes applied to human epidermis from aqueous solutions. Also included are each solute's physicochemical properties and the experimental conditions, such as temperature, skin thickness, and skin integrity, under which the data was generated. This database is limited to diluted or saturated aqueous solutions of solutes applied on human epidermal membranes or isolated stratum corneum in large volumes so that there was minimal change in the donor phase concentration. Included in this paper are univariate Quantitative Structure-epidermal Permeability Relationships (QSPR) in which the solute epidermal permeation parameters (kp, and Jmax) are related to potential individual solute physicochemical properties, such as molecular weight (MW), log octanol-water partition coefficient (log P), melting point (MP), hydrogen bonding (acceptor - Ha, donor – Hd), by scatter plots. This data was used in the associated review article to externally validate existing QSPR regression equations used to forecast the kp and Jmax for new therapeutic agents and chemicals. The data may also be useful in developing new QSPRs that may aid in: (1) drug choice and (2) product design for both topical and transdermal delivery, as well as (3) characterizing the potential skin exposure of hazardous substances.
登录
查看更多内容
影响因子:
14.9
作者:
Kim S;Chen J;Cheng T;Gindulyte A;He J;He S;Li Q;Shoemaker BA;Thiessen PA;Yu B;Zaslavsky L;Zhang J;Bolton EE
通讯作者:
Bolton EE
影响因子:
4.9
作者:
Milewski M;Stinchcomb AL
通讯作者:
Stinchcomb AL
影响因子:
4.6
作者:
Cronin, MTD;Dearden, JC;Murray-Dickson, G
通讯作者:
Murray-Dickson, G
影响因子:
3.2
作者:
FEDORS, RF
通讯作者:
FEDORS, RF
影响因子:
5.8
作者:
Moss, GP;Cronin, MTD
通讯作者:
Cronin, MTD